Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Demyelination coincides with numerous changes of gene expression in the central nervous system (CNS). Cystatin F, which is a papain‐like lysosomal cysteine proteinase inhibitor that is normally expressed by immune cells and not in the brain, is massively induced in the CNS during acute demyelination. We found that microglia, which are monocyte/macrophage‐lineage cells in the CNS, express cystatin F only during demyelination. By using several demyelinating animal models and the spinal cord tissues from multiple sclerosis (MS) patients, we examined spatiotemporal expression pattern of cystatin F by in situ hybridization and immunohistochemistry. We found that the timing of cystatin F induction matches with ongoing demyelination, and the places with cystatin F expression overlapped with the remyelinating area. Most interestingly, cystatin F induction ceased in chronic demyelination, in which remyelinating ability was lost. These findings demonstrate that the expression of cystatin F indicates the occurrence of ongoing demyelination/remyelination and the absence of cystatin F expression indicates the cessation of remyelination in the demyelinating area. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 1×
“The arrest of oligodendrocyte maturation has been thought of as an essential reason for remyelination impairment (Chang et al., 2002).”
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829 · cited 1×
“Osteopontin was induced in activated microglia during demyelination and offers a potential target in blocking the development of progressive MS by regulating T helper cell-1 (TH1)-mediated demyelinating disease (Chabas et al., 2001).”
BackgroundSelf-citationChen, Y., Wu, H., Wang, S., Koito, H., Li, J., Ye, F., Hoang, J., Escobar, S. S., Gow, A., Arnett, H. A., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2410 · Cited by 346 · cited 2×
“G proteincoupled receptor Gpr17 was expressed by oligodendrocyte lineage cells and negatively regulates oligodendrocyte differentiation and myelination (Chen et al., 2009); Jagged1 was induced in astrocytes in the brains of MS patients, and the Jagged1-Notch pathway was found to be involved in the inhibition of remyel…”
Mason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., & Matsushima, G. K. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63726-1 · Cited by 212
Mason, J. L., Langaman, C., Morell, P., Suzuki, K., & Matsushima, G. K. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00301.x · Cited by 172
Okuda, Y., Okuda, M., & Bernard, C. C. A. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00339-x · Cited by 77 · cited 1×
“The induction method of experimental autoimmune encephalomyelitis (EAE) was described previously (Okuda et al., 2002).”
MethodSelf-citation
Cited by
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Targeting RIPK1 for the treatment of human diseases
Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 408
RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395
Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction
Orre, M., Kamphuis, W., Osborn, L. M., Jansen, A. H. P., Kooijman, L., Bossers, K., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.004 · Cited by 394
Identification of a microglia phenotype supportive of remyelination
Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke, H. W. G. M. (2012) · Glia · doi:10.1002/glia.21266 · Cited by 358
“Since Ma et al. (2011) found a positive correlation between microglia cystatin-F expression and the regenerative capacity of the CNS tissue in multiple MS models and MS spinal cords as well, the expression profile of this particular enzyme in our study further supports our claim that the principal…”
Result
Metadata
- Authors
- Ma, J., Tanaka, K. F., Shimizu, T., Bernard, C. C. A., Kakita, A., Takahashi, H., Pfeiffer, S. E., & Ikenaka, K.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2011-02-22
- Volume
- 89
- Issue
- 5
- Pages
- 639-649
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2156351007
- Cited by
- 68
- References
- 6
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. https://app.cochat.ai/papers/10.1002/jnr.22567
- The paper
- Ma, J., Tanaka, K. F., Shimizu, T., Bernard, C. C. A., Kakita, A., Takahashi, H., Pfeiffer, S. E., & Ikenaka, K. (2011). Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.22567
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.